Aug 8 (Reuters) - Aclaris Therapeutics Inc
* Aclaris Therapeutics acquires Confluence Life Sciences, Inc.
* Aclaris Therapeutics Inc - at closing, aclaris paid approximately $10 million in cash
* Aclaris Therapeutics says also issued about 350,000 shares of its common stock of about $10 million on closing date, to former equityholders of confluence
* Aclaris Therapeutics - confluence equity holders eligible to receive up to additional $80 million in contingent payments upon achievement of certain milestones Source text for Eikon: Further company coverage: